{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:35:51Z","timestamp":1790303751184,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Department of Biomedical and Forensic Sciences"},{"name":"Anglia Ruskin University, Cambridge, UK"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.forsciint.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T11:54:29Z","timestamp":1535975669000},"page":"50-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases"],"prefix":"10.1016","volume":"292","author":[{"given":"Agatha","family":"Grela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0409-4724","authenticated-orcid":false,"given":"Lata","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2018.08.034_bib0005","series-title":"Guidelines for the Forensic Analysis of Drugs Facilitating Sexual Assault and Other Criminal Acts","author":"United Nations Office on Drugs and Crime","year":"2011"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0010","series-title":"An Overview of Sexual Offending in England and Wales","author":"Ministry of Justice, Home Office, Office for National Statistics","year":"2013"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1077801202250960","article-title":"The role of \u201creal rape\u201d and \u201creal victim\u201d stereotypes in the police reporting practices of sexually assaulted women","volume":"9","author":"Du Mont","year":"2003","journal-title":"Violence Against Women"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jip.1462","article-title":"Perceptions of male rape and sexual assault in a male sample from the United Kingdom: barriers to reporting and the impacts of victimization","volume":"14","author":"Hammond","year":"2016","journal-title":"J. Investig. Psychol. Offender Profiling"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3138\/cjwl.29.1.36","article-title":"Why doesn\u2019t she just report it? Apprehensions and contradictions for women who report sexual violence to the police","volume":"29","author":"Johnson","year":"2017","journal-title":"Can. J. Women Law"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0030","series-title":"I Was Sexually Assaulted by a Fellow Student \u2014 But My University Did Nothing","author":"Goldhill","year":"2015"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0035","series-title":"Drink Speaks the Truth: Forensic Investigation of Drug Facilitated Sexual Assaults","author":"Gautam","year":"2013"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0040","series-title":"Drug-facilitated Sexual Assault: A Forensic Handbook","author":"LeBeau","year":"2001"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1054\/jcfm.2001.0513","article-title":"Forensic urinalysis of drug use in cases of alleged sexual assault","volume":"8","author":"Hindmarch","year":"2001","journal-title":"J. Clin. Forensic Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcfm.2005.03.009","article-title":"Toxicological findings in cases of alleged drug facilitated sexual assault in the United Kingdom","volume":"12","author":"Scott-Ham","year":"2005","journal-title":"J. Clin. Forensic Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0055","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jflm.2008.05.006","article-title":"Alleged drug facilitated sexual assault (DFSA) in Northern Ireland from 1999 to 2005. A study of blood alcohol levels","volume":"15","author":"Hall","year":"2008","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jflm.2010.05.004","article-title":"Drug-facilitated sexual assault in Ontario, Canada: toxicological and DNA findings","volume":"17","author":"Du Mont","year":"2010","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jflm.2013.05.005","article-title":"Ethanol and drug findings in women consulting a sexual assault center \u2014 associations with clinical characteristics and suspicions of drug-facilitated sexual assault","volume":"20","author":"Hagemann","year":"2013","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0070","series-title":"Clarke\u2019s Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material","author":"Moffat","year":"2011"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcfm.2006.02.005","article-title":"The epidemiology of drug facilitated sexual assault","volume":"13","author":"Hurley","year":"2006","journal-title":"J. Clin. Forensic Med."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0080","series-title":"Drug Misuse: Findings from the 2014\/15 Crime Survey for England and Wales","author":"Office for National Statistics","year":"2015"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0085","series-title":"Adult Substance Misuse Statistics from the National Drug Treatment Monitoring System (NDTMS)","author":"Public Health England","year":"2016"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0090","series-title":"Sexual Assaults Facilitated by Drugs or Alcohol","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2008"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0095","series-title":"Drug Facts","author":"Alcohol and Drug Foundation","year":"2017"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0100","series-title":"The Analysis of Controlled Substances","author":"Cole","year":"2003"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0105","unstructured":"TripSit Factsheets, http:\/\/drugs.tripsit.me. (Accessed 23 July 2018)"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0110","series-title":"Amphetamine-Type Stimulants","author":"United Nations International Drug Control Programme","year":"1996"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0115","unstructured":"World Health Organization, Amphetamine-type Stimulants. http:\/\/www.who.int\/substance_abuse\/facts\/ATS\/en\/. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0120","series-title":"Inside The Dark, Dangerous World of Chemsex","author":"Strudwick","year":"2016"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0125","series-title":"Young People\u2019s Statistics from the National Drug Treatment Monitoring System","author":"Public Health Englandm","year":"2017"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0130","series-title":"Recommended Methods for the Identification and Analysis of Piperazines in Seized Materials","author":"United Nations Office on Drugs and Crime","year":"2013"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0135","series-title":"Drug Profiles","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2014"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0140","unstructured":"Erowid Methamphetamine Vault. https:\/\/erowid.org\/chemicals\/meth\/meth_dose.shtml. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0145","unstructured":"Erowid MDMA Vault. https:\/\/erowid.org\/chemicals\/mdma\/mdma_dose.shtml. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0150","unstructured":"Mephedrone Critical Review Report, 2014. http:\/\/www.who.int\/medicines\/areas\/quality_safety\/4_12_review.pdf. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0155","first-page":"100","article-title":"GC\u2013MS quantification method for mephedrone in plasma and urine: application to human pharmacokinetics","volume":"41","author":"Olesti","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/beem.2000.0055","article-title":"Central nervous system stimulants","volume":"14","author":"George","year":"2000","journal-title":"Baillieres Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0165","series-title":"Recommended Methods for the Identification and Analysis of Cocaine in Seized Materials","author":"United Nations of Drugs and Crime","year":"2012"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0170","series-title":"Estimate of the Incidence of Drug-facilitated Sexual Assault in the U.S.","author":"Negrusz","year":"2005"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0175","unstructured":"European Pharmacopoeia 7.0, 2010. http:\/\/www.fptl.ru\/biblioteka\/farmacop\/EP-7.0-2.pdf. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0180","unstructured":"NHS UK, Morphine. https:\/\/beta.nhs.uk\/medicines\/morphine. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0185","unstructured":"U.S. Department of Transportation, National Highway Traffic Safety Administration, Drugs and Human Performance Fact Sheets, https:\/\/www.wsp.wa.gov\/breathtest\/docs\/webdms\/DRE_Forms\/Publications\/drug\/Human_Performance_Drug_Fact_Sheets-NHTSA.pdf. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0190","unstructured":"F.A. Davis, Codeine, https:\/\/fadavispt.mhmedical.com\/content.aspx?bookid=1873\u00a7ionid=139006405. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0195","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/jps.2600621036","article-title":"Biological activity of pentobarbital metabolites","volume":"62","author":"Christensen","year":"1973","journal-title":"J. Pharm. Sci"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0200","unstructured":"NHS UK, Antidepressants. http:\/\/www.nhs.uk\/conditions\/Antidepressant-drugs\/Pages\/Introduction.aspx. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0205","unstructured":"NHS UK, Antihistamines. http:\/\/www.nhs.uk\/Conditions\/Antihistamines\/Pages\/Introduction.aspx. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0210","series-title":"New Zealand Data Sheet","author":"Bayer New Zealand Limited","year":"2016"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0215","series-title":"Diphenhydramine","author":"Davis","year":"2015"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0220","unstructured":"Chlorphenamine Elixir. https:\/\/www.drugs.com\/uk\/pdf\/leaflet\/1074213.pdf. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0225","series-title":"Citalopram 40 mg Tablets \u2014 Electronic Medicines Compendium","author":"Sandoz Ltd","year":"2013"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0230","series-title":"Neurotransmitters","author":"Purves","year":"2004"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0235","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0240","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12025","article-title":"How theories evolved concerning the mechanism of action of barbiturates","volume":"53","author":"L\u00f6scher","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0245","first-page":"15","article-title":"Neural mechanisms of the reinforcing action of cocaine","volume":"50","author":"Wise","year":"1984","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0250","series-title":"Cocaine","author":"National Institute on Drug Abuse","year":"2016"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0255","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1523\/JNEUROSCI.1033-13.2013","article-title":"Amphetamine mechanisms and actions at the dopamine terminal revisited","volume":"33","author":"Calipari","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0260","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2165\/00003495-197612040-00002","article-title":"Antihistamines: pharmacology and clinical use","volume":"12","author":"Pearlman","year":"1976","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0265","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","article-title":"Histamine and its receptors","volume":"147","author":"Parsons","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0270","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0275","unstructured":"M. Trivedi, S. Shaikh, C. Gwinnutt, Pharmacology of Opioids. https:\/\/www.aagbi.org\/sites\/default\/files\/64-Pharmacology-of-Opioids-part-I.pdf. (Accessed 23 July 2018)."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0280","first-page":"132","article-title":"Opioid peptides","volume":"21","author":"Froehlich","year":"1997","journal-title":"Alcohol Heal Res. World."},{"key":"10.1016\/j.forsciint.2018.08.034_bib0285","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"key":"10.1016\/j.forsciint.2018.08.034_bib0290","first-page":"445","article-title":"Brain mechanisms of drug reward and euphoria","volume":"3","author":"Wise","year":"1985","journal-title":"Psychiatr. Med."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073818306674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073818306674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:54:30Z","timestamp":1759946070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073818306674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":58,"alternative-id":["S0379073818306674"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.08.034","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}